CLINICAL_TRIALS
trial_result
· 2019-03-01
Clinical Trial Update: ACVDL Treatment for Patients With Newly Diagnosed Multiple Myeloma [Phase 2]
Summary
Phase 2 clinical trial update for ACVDL treatment in newly diagnosed multiple myeloma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vejle Hospital | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED